Scotland reaches access agreement with Vertex for CF drug Orkambi
Vertex Pharmaceuticals has announced two of its cystic fibrosis (CF) drugs, Orkambi (lumacaftor-ivacaftor) and Symkevi...
Read More...
Focus:
Scotland
-
Eisai forms PROTACs research collaboration
Eisai has formed a research collaboration to support oncology drug discovery using proteolysis targeting chimeras...
Read More...
-
![Medicines Manufacturing Innovation Centre]()
Medicines Manufacturing Innovation Centre, Renfrewshire
The Centre for Process Innovation (CPI), the University of Strathclyde, Scottish Enterprise, Innovate UK, AstraZeneca...
Read More...
-
Deals this week: Medicines for Malaria Venture, Swedish Orphan Biovitrum, aTyr Pharma
Medicines for Malaria Venture (MMV) has entered a collaboration with Drugs for Neglected Disease initiative...
Read More...
-
![Scottish pharmaceutical sector]()
Pharmaceutical industry worth £1.7bn to Scottish economy
Scotland's pharmaceutical sector is worth £1.7bn (gross value added) to the country’s economy, according to...
Read More...
-
![SCFE]()
Research suggests childhood obesity major risk factor for hip disease
New research has revealed that childhood obesity is causing growing number of adolescents to develop...
Read More...
-
![]()
EUSA Pharma’s tivozanib drug approved for kidney cancer in Scotland
Scotland’s pharmaceutical regulatory authority the Scottish Medicines Consortium (SMC) has recommended Jazz Pharmaceutical spin-off EUSA...
Read More...
-
![]()
Glasgow University uncovers molecular structure of herpes virus
Researchers from the University of Glasgow have used Nobel prize-winning cryo-electron microscopy (cryo-EM) to reveal...
Read More...
-
Deals and M&As this week: Alliance Pharma, Bayer, Onxeo
Alliance Pharma plans to acquire exclusive distribution rights to Nizoral, an anti-dandruff brand, from Janssen...
Read More...
Go Top
